These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 7254147)

  • 41. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinico-morphologic characteristics of X-linked pseudohypertrophic myopathy].
    Demidov PV; Kop'eva TN; Potomskaia IZ; Grinio LP; Kopylova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):641-6. PubMed ID: 936862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlations between aldolasaemia and motor unit territory in the evaluation of Duchenne's progressive muscular dystrophy.
    Radu H; Migea S; Bordeianu L; Radu A; Ciunganu B
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):415-6. PubMed ID: 4176628
    [No Abstract]   [Full Text] [Related]  

  • 45. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
    Caruso G; Campanella G
    Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
    [No Abstract]   [Full Text] [Related]  

  • 46. [Laboratory ultramicroanalysis in pediatric practice. 3. Spectrophotometric analysis of some serum enzyme activities and normal values in childhood].
    Natoli G; Lapi AS; Mancini G; Gerlini G; Natoli V
    Arch Ital Pediatr Pueric; 1966; 24(5):373-417. PubMed ID: 5991320
    [No Abstract]   [Full Text] [Related]  

  • 47. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum enzymes in disease of skeletal muscle.
    Rosalki SB
    Clin Lab Med; 1989 Dec; 9(4):767-81. PubMed ID: 2686911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinico-statistical considerations on a group of 22 patients with progressive muscular dystrophy].
    Garofalo E; Marcer V
    Fracastoro; 1966; 59(6):621-38. PubMed ID: 5998705
    [No Abstract]   [Full Text] [Related]  

  • 51. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative study of the enzyme activity of muscle tissue of normal children and children with progressive muscular dystrophy at different stages of the disease].
    Hooft C; De Laey P; Lambert Y
    Rev Fr Etud Clin Biol; 1966 May; 11(5):510-1. PubMed ID: 5938397
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical experimental studies of the activity of a cellular extract (TRF). 3. Activity in muscular diseases].
    Del Giudice E; De Luca R; Del Prete A; Sepe O; Federico P; Portone N; Spagnoletti G
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1868-71. PubMed ID: 5735735
    [No Abstract]   [Full Text] [Related]  

  • 54. [Contribution to the study of the enzymology of primary myopathies of childhood].
    Vitetta M
    Biol Lat; 1965; 18(4):359-66. PubMed ID: 5871253
    [No Abstract]   [Full Text] [Related]  

  • 55. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical studies in progressive muscular dystrophy].
    Prot J
    Neurol Neurochir Pol; 1971; 5(4):473-8. PubMed ID: 5122052
    [No Abstract]   [Full Text] [Related]  

  • 57. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy.
    N Engl J Med; 1978 Jun; 298(26):1479-80. PubMed ID: 652021
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of the simultaneous administration of diethylstilbestrol and prednisolone on serum enzymes in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    J Med; 1977; 8(2):123-34. PubMed ID: 268398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum CPK activities in long term follow up cases of progressive muscular dystrophy of Duchenne's type -with special reference to the course of disability and body weight (author's transl)].
    Konagaya M; Kohno K; Takayanagi T; Sobue I
    Rinsho Shinkeigaku; 1981 Feb; 21(2):150-7. PubMed ID: 7261497
    [No Abstract]   [Full Text] [Related]  

  • 60. [Modern laboratory methods for diagnosis and prevention of progressive dystrophy].
    Mariani E; Bianchini A
    Riv Neurol; 1968; 38(5):465-8. PubMed ID: 5699645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.